Accurate, Focused Research on Law, Technology and Knowledge Discovery With Daily Postings Since 2002
CDC, September 12, 2023: Updated COVID-19 vaccines are recommended for everyone 6 months and older and will be available by the end of this week at most places you would normally go to get your vaccines. Older adults and persons with weakened immune systems are at greatest risk for hospitalization and death. In addition, healthy …
Chronicle of Higher Education [read free]: “Over the past 20 years, a wave of improbable-sounding scientific research has come under the microscope. Are Asian Americans really prone to heart attacks on the fourth day of every month? Do power poses really increase testosterone? Do men really eat more pizza when women are around? Are people …
Vaccines.gov: COVID-19 vaccination guidance has been updated. Learn more about COVID‑19 vaccine recommendations. Search for COVID‑19 vaccine options for children or adults to find a location near you. If you do not find a convenient location, check back later or contact your health care provider or local health department. Search for vaccine using your 5-digit …
NYT via Chicago Tribune – “The latest COVID-19 boosters are expected to be approved by the Food and Drug Administration as early as Monday, arriving alongside the seasonal flu vaccine and shots to protect infants and older adults from RSV, a potentially lethal respiratory virus. The Centers for Disease Control and Prevention is expected to …
HHS Agency for Healthcare Research and Quality: “The Physician and Physician Practice Research Database (3P-RD) captures characteristics of physicians and physician practices in 13 states. The database describes the supply of physician services available across selected states for data year 2019-2020. AHRQ created 3P-RD as a resource to address existing data gaps in physician health …
“The Autoimmune Registry has determined that biomarkers of immune system activity similar to those seen in many autoimmune and autoinflammatory diseases justify the inclusion of Long COVID on its list of diseases. [1,2,3] As many as 50% of people who contract COVID-19 develop the syndrome known as “Long COVID”, which appears to affect a person …
The State Dept. created a new agency to deal with diseases as national security threats. “Health security is national security, and an infectious disease threat anywhere is a threat everywhere. U.S. leadership is critical to save lives domestically and globally by preventing, detecting, and responding to these health threats, in collaboration with international partners. The …
J Med Internet Res 2023;25:e48659 Background: Large language model (LLM)–based artificial intelligence chatbots direct the power of large training data sets toward successive, related tasks as opposed to single-ask tasks, for which artificial intelligence already achieves impressive performance. The capacity of LLMs to assist in the full scope of iterative clinical reasoning via successive prompting, …
Current and Resolved Drug Shortages and Discontinuations Reported to FDA Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages Search by Generic Name or Active Ingredient: Enter at least three characters A drug receives Resolved status when the Drug Shortages Staff (DSS) determines …
Nate Bear: “A recent article in The Atlantic asked “is covid a common cold yet?” The answer was not quite, but they happily tell the reader that the symptoms have changed a lot and we’re on the way. The Atlantic is not an outlier. Much mainstream coverage has focused on covid’s ‘cold-like’ symptoms, neglecting to …
Journal of Internet Medical Research [full text free] Published on 25.7.2023 in Vol 25 (2023) Background: People living with dementia or other cognitive decline and their caregivers (PLWD) increasingly rely on the web to find information about their condition and available resources and services. The recent advancements in large language models (LLMs), such as ChatGPT, …
PLOS – Absolutely Maybe: “This update is packed with news, with 3 developments standing out in particular. The first is the “major hat” in this post’s title. It’s a new consortium of major scientific groups, along with a major global pharmaceutical company, spanning bases in Israel, the US, and Europe. That’s everything that’s needed for …
